HealthcareServices

Nasal Polyps Treatment Market Performance Outlook 2026–2030: Revenue to Hit $8.9 Billion at 9.4% CAGR

March 2, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the nasal polyps treatment market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Nasal Polyps Treatment Market between 2026 and 2030?

The nasal polyps treatment market size has shown substantial growth in recent years. This market is set to expand from $5.68 billion in 2025 to $6.22 billion in 2026, progressing at a compound annual growth rate (CAGR) of 9.6%. The expansion observed in the past period is attributed to the prevalence of chronic sinusitis, increasing allergy-associated nasal disorders, reliance on corticosteroid-based treatments, growing adoption of endoscopic sinus surgery, and limited biologic treatment options.

The nasal polyps treatment market is anticipated to show significant expansion over the next few years. It is projected to reach $8.9 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%.

This growth during the forecast period can be attributed to several factors, including the increasing demand for targeted biologic drugs, heightened research and development in nasal therapeutics, the expansion of outpatient minimally invasive procedures, growing awareness surrounding nasal polyp management, and the introduction of innovative anti-inflammatory formulations.

Prominent trends expected during the forecast period involve the rising adoption of biologic therapies for chronic nasal polyps, an increasing demand for minimally invasive sinus procedures, the growing utilization of combination therapy for persistent cases, an expanding preference for nasal corticosteroid sprays, and an increase in clinical trials for novel anti-inflammatory drugs.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7109&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Nasal Polyps Treatment Market?

The nasal polyps treatment market is projected to be influenced by growing healthcare expenditure. Healthcare expenditure signifies the overall financial assets disbursed by individuals, governments, and various organizations within a specific healthcare system to cover expenses related to medical services, treatments, medications, and healthcare infrastructure. As healthcare budgets expand, there will likely be greater funds dedicated to the diagnosis, management, and treatment of nasal polyps. This financial dedication can enhance patient access to advanced therapies, innovative treatment options, and improved research and development, ultimately boosting the market’s growth. For instance, in April 2025, according to the Office for National Statistics, a UK-based statistics authority, the UK government’s net research and development expenditure increased to £17.4 billion (~US$21.8 billion) in 2023 from £16.1 billion (~US$20.1 billion) in 2022, reflecting an 8.2% rise. Therefore, increasing healthcare expenditure is driving the nasal polyps treatment market.

What Segments Are Included Within The Nasal Polyps Treatment Market?

The nasal polyps treatment market covered in this report is segmented –

1) By Type: Pharmacological Therapies, Surgeries

2) By Route: Oral, Nasal, Other Routes

3) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Pharmacological Therapies: Corticosteroids, Biologics, Antihistamines, Saline Nasal Irrigation

2) By Surgeries: Polypectomy, Endoscopic Sinus Surgery, Balloon Sinus Dilation, Revision Sinus Surgery

Which Trends Are Influencing The Development Of The Nasal Polyps Treatment Market?

Leading companies within the Nasal Polyps Treatment market are actively pursuing Food and Drug Administration (FDA) approvals for the launch of new treatments. Food and Drug Administration (FDA) approvals are the official regulatory processes through which the U.S. FDA assesses and sanctions the marketing and distribution of drugs, medical devices, and food products, guaranteeing their safety and effectiveness for public use. For instance, in September 2024, Regeneron Pharmaceuticals, Inc., a US-based biopharmaceutical company, and Sanofi SA, a France-based pharmaceutical and healthcare company, announced the U.S. Food and Drug Administration (FDA) approval of Dupixent (dupilumab). This approval designates it as an add-on maintenance treatment for adolescent patients aged 12 to 17 years suffering from inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP). This authorization establishes it as the first and only biologic treatment specifically indicated for this age bracket. The approval addresses the unmet medical needs of approximately 9,000 U.S. adolescents affected by CRSwNP, providing a novel option that improves symptoms, minimizes nasal polyp recurrence, and enhances their overall quality of life.

Who Are The Top-Performing Companies In The Nasal Polyps Treatment Market In Recent Years?

Major companies operating in the nasal polyps treatment market are Sanofi SA, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., AstraZeneca plc, Cipla Ltd., Dr. Reddy’s Laboratories Ltd., Genentech Inc., Glenmark Pharmaceuticals Ltd., Lupin Limited, Novartis AG, Optinose US Inc., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Cadila Ltd., Amgen Inc., Takeda Pharmaceutical Company Ltd., Eli Lilly and Company, Daiichi Sankyo Company Ltd., Shionogi Co Ltd, Astellas Pharma Inc., Allakos Inc, Lyra Therapeutics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/nasal-polyps-treatment-global-market-report

How Does The Nasal Polyps Treatment Market Perform Across Major Global Regions?

North America was the largest region in the nasal polyps treatment market in 2025 Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal polyps treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Nasal Polyps Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7109&type=smp

Browse Through More Reports Similar to the Global Nasal Polyps Treatment Market 2026, By The Business Research Company

Nasal Drug Delivery Technology Market Report 2026

https://www.thebusinessresearchcompany.com/report/nasal-drug-delivery-technology-global-market-report

Chronic Rhinosinusitis With Nasal Polyps Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-rhinosinusitis-with-nasal-polyps-global-market-report

Nasal Splints Market Report 2026

https://www.thebusinessresearchcompany.com/report/nasal-splints-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795